
Number of publications published per year by Lian, Zhe-Xiong. (Source : PubMed)

Distribution of publications types for Lian, Zhe-Xiong. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.
Hepatology
2009;50;6

Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production.
Gastroenterology
2009;137;6

Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.
Hepatology
2009;50;5

Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis.
Clin. Exp. Immunol.
2009;157;3

Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride.
Hepatology
2009;49;5


Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.
Clin. Exp. Immunol.
2009;155;3

B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.
Gastroenterology
2009;136;3
Hepatic IL-17 responses in human and murine primary biliary cirrhosis.
J. Autoimmun.
2009;32;1

Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis.
Hepatology
2009;49;2

Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice.
Hepatology
2009;49;1
[ See timeline ] [ See all publications ]
means that Lian, Zhe-Xiong has 19 papers cited a least 19 times - methodology
Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis, CA 95616, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.